Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip A Philip, MD, PhD, FRCP
Karmanos Cancer Institute at Wayne State University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Erasme
Brussels, Brussels Capital, Belgium
- Uz Leuven
Leuven, VBR, Belgium
- Chru Brest - Hôpital Morvan
Brest, France
- Hôpital Beaujon
Clichy, France
- Centre Hospitalier Départemental Vendée - Hôpital de la Roche-Sur-Yon
La Roche-sur-Yon, France
- L'Icm, Institut Régional Du Cancer de Montpellier
Montpellier, France
- Chu de Nantes - Hôpital Nord Laennec
Nantes, France
- Chu Hopitaux de Bordeaux - Hôpital Saint-André
Pessac, France
- Chu de Poitiers
Poitiers, France
- Centre Eugène Marquis
Rennes, France
- Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France
- Gustave Roussy Cancer Campus Grand Paris (institut de Cancerologie Gustave-Roussy)
Villejuif, France
- Slk-Kliniken Heilbronn Gmbh
Heilbronn, Baden-Wurttemberg, Germany
- Universitätsklinikum Knappschaftskrankenhaus Bochum Gmbh
Bochum, Germany
- Universitaetsklinikum Tuebingen
Tübingen, Germany
- Hillel Yaffe Medical Center
Hadera, Haifa District, Israel
- Rambam Medical Center
Haifa, Israel
- Shaare Zedek Medical Center
Jerusalem, Israel
- Sanz Medical Center - Laniado Hospital
Netanya, Israel
- the Chaim Sheba Medical Center - Sheba Cancer Research Center (scrc)
Ramat Gan, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Assaf-Harofeh Medical Center
Ẕerifin, Israel
- the Catholic University of Korea - Seoul St. Mary'S Hospital (kangnam St. Mary'S Hospital)
Seocho, Seoul, South Korea
- Seoul National University Hospital
Busan, South Korea
- Kyungpook National University Chilgok Hospital
Daegu, South Korea
- Gachon University Gil Hospital
Incheon, South Korea
- Inha University Hospital
Incheon, South Korea
- Seoul National University Bundang Hospital
Seongnam-si, South Korea
- Korea University Anam Hospital
Seoul, South Korea
- National Cancer Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- City of Hope
Duarte, California, United States
- Ucla Medical Center
Los Angeles, California, United States
- Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Pacific Hematology Oncology Associates
San Francisco, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2018
- Primary completion
- 16 Aug 2021
- Completion
- 2 Jan 2022
- Last update posted
- 3 Jan 2023
- Registered enrollment
- 528
- Registry id
- NCT03504423
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.